Search Results

This report highlights the issues surrounding high prices and poor supply of the drugs needed to treat drug-resistant tuberculosis (DR-TB). The report provides an overview of available drug-resistant TB medicines, including drug sources, quality status, and price.

This report analyses the factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. Detailed pricing profiles of key DR-TB drugs are also provided.

The Global Drug Facility (GDF) is a mechanism to expand access to, and availability of, high-quality anti-TB drugs and diagnostics to support the Stop TB Strategy.

This document outlines progress that GDF has made to date, what still needs to be done and where high-level advocacy could help GDF to...

This booklet calls upon national programs for TB control, donors, financing institutions, civil society, media, and communities to join hands in intensifying the fight against drug-resistant TB.

This new report on anti-tuberculosis (TB) drug resistance by the World Health Organization (WHO) updates “Anti-tuberculosis drug resistance in the world: Report No. 4” published by WHO in 2008. It summarizes the latest data and provides latest estimates of the global epidemic of multidrug and...

This tool will assist countries and partners in conducting assessments of national tuberculosis (TB) programs to identify strengths and gaps related to preventing, diagnosing, and treating multidrug-resistant TB. It provides the starting point for planning for new activities to address drug...

This fact sheet provides an overview of multidrug-resistant tuberculosis (MDR TB) and extensively drug-resistant tuberculosis (XDR TB). This fact sheet covers definitions, symptoms, treatment, transmission, and prevention.

This fact sheet provides an overview of multidrug-resistant tuberculosis (MDR TB) and extensively drug-resistant tuberculosis (XDR TB). This fact sheet covers definitions, symptoms, treatment, transmission, and prevention.

This report presents results from an expert panel convened by CDC to examine the current status of rapid drug-resistance (DR) testing in the United States; to research published evidence and current guidelines; and to provide guidance and make recommendations to CDC for developing a system to...

This fact sheet provides general information on TB drug resistance.